The Important — And Overlooked — Caveat Behind Pfizer’s Rival To Novo Nordisk In Diabetes
It’s the heyday for a specific class of diabetes drugs, an analyst said Tuesday after Pfizer (PFE) stock surged on the results of its study in patients with diabetes. On Monday, a paper from the […]